Ellipse Pharma

Ellipse Pharma is a French contract development and manufacturing organization (CDMO) specializing in the formulation of complex drug products. The company focuses on enhancing the bioavailability of poorly soluble active pharmaceutical ingredients (APIs) using advanced lipid-based delivery systems. Ellipse Pharma provides a range of services from pre-formulation and analytical development to the production of clinical batches for Phase 1 and Phase 2 trials. Their expertise includes various dosage forms such as capsules, liquids, and semi-solids, supported by state-of-the-art GMP manufacturing facilities. The company is a key partner for biotech and pharma firms looking to overcome solubility and permeability challenges in early-stage development.